A. Athanassiadou

M. Pericak-Vance, M. Polymeropoulos, R. Nussbaum, 1998, DNA research : an international journal for rapid publication of reports on genes and genomes.

Efficient episomal gene transfer to human hepatic cells using the pFAR4–S/MAR vector

D. Scherman, A. Athanassiadou, C. Marie, 2019, Molecular Biology Reports.

Lack of Fas (APO-1/CD95) gene structural alterations or transcript variant ratio changes in breast cancer.

G. Voutsinas, V. Gorgoulis, A. Kotsinas, 2003, Cancer letters.

Molecular Cloning and Expression of Aven Gene in Chicken

I. Zarkadis, A. Athanassiadou, Angeliki Mikrou, 2011, The Protein Journal.

The β-globin Replicator greatly enhances the potential of S/MAR based episomal vectors for gene transfer into human haematopoietic progenitor cells

E. Papapetrou, A. Athanassiadou, A. Spyridonidis, 2017, Scientific Reports.

Detection and genetic analysis of β‐thalassemia mutations by competitive oligopriming

R. Gibbs, A. Athanassiadou, A. Papachatzopoulou, 1995 .

Efficient episomal gene transfer to human hepatic cells using the pFAR4–S/MAR vector

D. Scherman, A. Athanassiadou, C. Marie, 2019, Molecular Biology Reports.

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

S E Ide, A. Dehejia, M. Polymeropoulos, 1997, Science.

Advances in the Development and the Applications of Nonviral, Episomal Vectors for Gene Therapy

V. Picanço-Castro, A. Athanassiadou, M. Figueiredo, 2021, Human gene therapy.

The functional role of S/MARs in episomal vectors as defined by the stress-induced destabilization profile of the vector sequences.

A. Thrasher, I. Zarkadis, A. Athanassiadou, 2009, Journal of molecular biology.

Glutathione S‐transferase polymorphisms and onset age in α‐synuclein A53T mutant Parkinson's disease

J. Vance, L. Golbe, W. Johnson, 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Region-Specific Genetic Heterogeneity of HBB Mutation Distribution in South-Western Greece

G. Patrinos, A. Vantarakis, Adamantia Papachatzopoulou, 2010, Hemoglobin.

Genotypic heterogeneity and correlation to intergenic haplotype within high HbF β‐thalassemia intermedia

A. Sgourou, Adamantia Papachatzopoulou, A. Athanassiadou, 2006, European journal of haematology.

Detection of hepatitis B virus DNA in chronic carriers of hepatitis B surface antigen in southwestern Greece

A. Athanassiadou, E. Anastassiou, M. Christofidou, 1995, European Journal of Clinical Microbiology and Infectious Diseases.

A novel β‐thalassaemia mutation in the 5’untranslated region of the β‐globin gene

R. Gibbs, A. Athanassiadou, A. Papachatzopoulou, 1994 .

Motor and Nonmotor Features of Carriers of the p.A53T Alpha‐Synuclein Mutation: A Longitudinal Study

M. Stamelou, S. Papageorgiou, L. Stefanis, 2016, Movement disorders : official journal of the Movement Disorder Society.

Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein.

M. Polymeropoulos, G. Voutsinas, E. Leroy, 1999, American journal of human genetics.

Genetic modification of hematopoietic stem cells with nonviral systems: past progress and future prospects

E. Papapetrou, A. Athanassiadou, A Athanassiadou, 2005, Gene Therapy.

Detection of gene rearrangements in reactive lymphoid processes.

D. Anagnostou, A. Athanassiadou, T. Papadaki, 1993, Leukemia & lymphoma.

LCR-mediated, long-term tissue-specific gene expression within replicating episomal plasmid and cosmid vectors

S. Raguz, F. Grosveld, L. Harland, 2002, Gene Therapy.

Gene therapy for the haemoglobinopathies

A. Athanassiadou, 2005 .

Allelic imbalance of expression and epigenetic regulation within the alpha‐synuclein wild‐type and p.Ala53Thr alleles in Parkinson disease

A. Verkerk, P. J. van der Spek, G. Patrinos, 2010, Human mutation.

Beta-thalassaemia and the prevalence of HCV viraemia.

G. Dimitracopoulos, A. Athanassiadou, F. Kolonitsiou, 1995, Haematologia.

Clinical phenotype in patients with α-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease

M. Polymeropoulos, A. Papadimitriou, S. Papapetropoulos, 2001, Journal of neurology, neurosurgery, and psychiatry.

cDNA cloning of the translocon associated protein beta-subunit in the chick cerebellum.

J. Papamatheakis, D. Thanos, I. Zarkadis, 1997, Gene.

Emerging patent landscape for non-viral vectors used for gene therapy

D. Covas, V. Picanço-Castro, A. Athanassiadou, 2020, Nature Biotechnology.

Mutation screening of the Wolfram syndrome gene in psychiatric patients

D. Collier, M. Polymeropoulos, R. Torres, 2001, Molecular Psychiatry.

Clinical characteristics of the alpha‐synuclein mutation (G209A)‐associated Parkinson's disease in comparison with other forms of familial Parkinson's disease in Greece

S. Papapetropoulos, A. Papadimitriou, J. Ellul, 2003, European journal of neurology.

Cytochrome P450 2C19 polymorphism and antiplatelet therapy. Who should really be genotyped?

D. Alexopoulos, A. Athanassiadou, G. Kassimis, 2013, Current pharmaceutical design.

Nitric oxide synthase expression, enzyme activity and NO production during angiogenesis in the chick chorioallantoic membrane

E. Papadimitriou, C. Flordellis, S. Kritikou, 2000, British journal of pharmacology.

An in vitro system for expression analysis of mutations of the β‐globin gene: validation and application to two mutations in the 5′ UTR

J. Sloane-Stanley, S. Thein, W. Wood, 1999, British journal of haematology.

Glutathione S-transferase polymorphisms and onset age in alpha-synuclein A53T mutant Parkinson's disease.

J. Vance, L. Golbe, W. Johnson, 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.